166 related articles for article (PubMed ID: 17160023)
1. Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells.
Burwell EA; McCarty GP; Simpson LA; Thompson KA; Loeb DM
Oncogene; 2007 May; 26(23):3423-30. PubMed ID: 17160023
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
[TBL] [Abstract][Full Text] [Related]
3. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
Jomgeow T; Oji Y; Tsuji N; Ikeda Y; Ito K; Tsuda A; Nakazawa T; Tatsumi N; Sakaguchi N; Takashima S; Shirakata T; Nishida S; Hosen N; Kawakami M; Tsuboi A; Oka Y; Itoh K; Sugiyama H
Cancer Sci; 2006 Apr; 97(4):259-70. PubMed ID: 16630117
[TBL] [Abstract][Full Text] [Related]
5. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.
Zamora-Avila DE; Franco-Molina MA; Trejo-Avila LM; Rodríguez-Padilla C; Reséndez-Pérez D; Zapata-Benavides P
Melanoma Res; 2007 Dec; 17(6):341-8. PubMed ID: 17992115
[TBL] [Abstract][Full Text] [Related]
6. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
Smith SI; Down M; Boyd AW; Li CL
Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
[TBL] [Abstract][Full Text] [Related]
8. Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway.
Ito K; Oji Y; Tatsumi N; Shimizu S; Kanai Y; Nakazawa T; Asada M; Jomgeow T; Aoyagi S; Nakano Y; Tamaki H; Sakaguchi N; Shirakata T; Nishida S; Kawakami M; Tsuboi A; Oka Y; Tsujimoto Y; Sugiyama H
Oncogene; 2006 Jul; 25(30):4217-29. PubMed ID: 16518414
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR quantification of major Wilms' tumor gene 1 (WT1) isoforms in acute myeloid leukemia, their characteristic expression patterns and possible functional consequences.
Kramarzova K; Stuchly J; Willasch A; Gruhn B; Schwarz J; Cermak J; Machova-Polakova K; Fuchs O; Stary J; Trka J; Boublikova L
Leukemia; 2012 Sep; 26(9):2086-95. PubMed ID: 22430637
[TBL] [Abstract][Full Text] [Related]
10. Expression of the WT1 gene -KTS domain isoforms suppresses the invasive ability of human lung squamous cell carcinoma cells.
Moriya S; Takiguchi M; Seki N
Int J Oncol; 2008 Feb; 32(2):349-56. PubMed ID: 18202757
[TBL] [Abstract][Full Text] [Related]
11. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
12. c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation.
Jenndahl LE; Isakson P; Baeckström D
Int J Oncol; 2005 Aug; 27(2):439-48. PubMed ID: 16010426
[TBL] [Abstract][Full Text] [Related]
13. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
[TBL] [Abstract][Full Text] [Related]
14. A cell-autonomous role for WT1 in regulating Sry in vivo.
Bradford ST; Wilhelm D; Bandiera R; Vidal V; Schedl A; Koopman P
Hum Mol Genet; 2009 Sep; 18(18):3429-38. PubMed ID: 19549635
[TBL] [Abstract][Full Text] [Related]
15. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor protein 1: an early target of progestin regulation in T-47D breast cancer cells that modulates proliferation and differentiation.
Caldon CE; Lee CS; Sutherland RL; Musgrove EA
Oncogene; 2008 Jan; 27(1):126-38. PubMed ID: 17599043
[TBL] [Abstract][Full Text] [Related]
17. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
[TBL] [Abstract][Full Text] [Related]
19. [The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].
Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):543-7. PubMed ID: 16468332
[TBL] [Abstract][Full Text] [Related]
20. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
